Characterization of a Novel Isoform of α-Nascent Polypeptide-associated Complex as IgE-defined Autoantigen  by Mossabeb, Roschanak et al.
Characterization of a Novel Isoform of a-Nascent
Polypeptide-associated Complex as IgE-de®ned Autoantigen
Roschanak Mossabeb, Susanne Seiberler, Irene Mittermann, Renate Reininger,* Susanne Spitzauer,*
Susanne Natter, Petra Verdino,² Walter Keller,² Dietrich Kraft, and Rudolf Valenta
Department of Pathophysiology, *Clinical Institute for Medical and Chemical Laboratory Diagnostics, University of Vienna, Austria; ²Institute of
Chemistry and Structural Biology, Karl-Franzens-University Graz, Austria
The nascent polypeptide-associated complex is
required for intracellular translocation of newly
synthesized polypeptides in eukaryotic cells. It may
also act as a transcriptional coactivator in humans
and various eukaryotic organisms and binds to
nucleic acids. Recently, we provided evidence that a
component of nascent polypeptide-associated com-
plex, a-nascent polypeptide-associated complex, rep-
resents an IgE-reactive autoantigen for atopic
dermatitis patients. By oligonucleotide screening we
isolated a complete cDNA coding for a so far
unknown a-nascent polypeptide-associated complex
isoform from a human epithelial cDNA library.
Southern blot hybridization experiments provided
further evidence that a-nascent polypeptide-associ-
ated complex is encoded by a gene family.
Recombinant a-nascent polypeptide-associated com-
plex was expressed in Escherichia coli as a soluble,
His-tagged protein, and puri®ed via nickel af®nity
chromatography. By circular dichroism analysis it is
demonstrated that puri®ed recombinant a-nascent
polypeptide-associated complex represents a folded
protein of mixed a-helical and b-sheet conformation
with unusual high thermal stability and remarkable
refolding capacity. Complete recombinant a-nascent
polypeptide-associated complex (215 amino acids)
and its 86 amino acid C-terminal fragment speci®c-
ally bound IgE autoantibodies. Recombinant a-nas-
cent polypeptide-associated complex also inhibited
IgE binding to natural a-nascent polypeptide-associ-
ated complex, demonstrating the presence of com-
mon IgE epitopes between the recombinant and
natural protein. Furthermore, recombinant a-nas-
cent polypeptide-associated complex induced speci®c
lymphoproliferative responses in peripheral blood
mononuclear cells of a sensitized atopic dermatitis
patient. As has been proposed for environmental
allergens it is possible that T cell responses to IgE-
de®ned autoantigens may contribute to the chronic
skin manifestations in atopic dermatitis. Key words:
allergy/atopic dermatitis/autoantigen/circular dichroism/
nascent polypeptide-associated complex. J Invest Dermatol
119:820±829, 2002
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topy is a genetically determined hypersensitivity
disease that is based on the production of IgE
antibodies against per se harmless antigens (i.e.,
allergens) (Kay, 1997). Allergens can be derived from
a variety of environmental allergen sources (e.g.,
pollens, mites, moulds, animals, food) and may induce a variety of
allergic manifestations, including allergic rhinoconjunctivitis,
allergic asthma, food allergy, anaphylaxis, and atopic dermatitis
(AD). AD is different from other forms of acute allergic
manifestations as it mainly resembles features of a cell-mediated,
type IV-like immune reaction (Werfel et al, 1996; Herz et al, 1998;
Wistokat-Wul®ng et al, 1999; Leung, 2000; Wollenberg and
Bieber, 2000). In addition, AD patients frequently contain high
levels of IgE antibodies directed against a variety of exogenous
allergens. Recently, we found that a large proportion of patients
suffering from AD exhibit IgE reactivity also to human proteins,
which are expressed in a variety of cell and tissue types (Valenta et al,
1996).
Using serum IgE autoantibodies from a patient suffering from
severe AD we have isolated cDNAs coding for IgE-reactive
autoantigens (Valenta et al, 1998). One of these cDNA coded for a
C-terminal portion of a-nascent polypeptide-associated complex
(a-NAC) (Natter et al, 1998), a phylogenetically well conserved
protein (humans, animals, insects, plants, yeast), which represents a
component of the NAC (Wiedmann et al, 1994). It is likely one of
the ®rst cytosolic factors that contacts nascent polypeptides when
they emerge from the ribosome and is involved in the correct
targeting and translocation of intracellular polypeptides (Wang et al,
1995). In addition, a-NAC was described as developmentally
regulated transcriptional coactivator (Yotov and Arnaud, 1996) and
recently was shown to bind to nucleic acids (Beatrix et al, 2000;
Whitby and Dixon, 2001).
Here we report the molecular characterization of the IgE
autoantigen, a-NAC, which according to the allergen nomenclat-
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Figure 1. Comparison of the cDNA sequence of Hom s 2.01 with the cDNA sequence of human a-NAC and a partial Hom s 2.02
cDNA. Nucleotides of the coding region were printed in capital letters, whereas those of the noncoding regions are shown in lower case letters.
Identical nucleotides were indicated by dashes in the alignment. EcoRI sites are printed in italics and are underlined. The stop codon is indicated by an
asterisk. The DNA and deduced amino acid sequence of Hom s 2.01 have been submitted to the EMBL Nucleotide Sequence Database under the
accession number: AJ278883.
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ure system was designated Hom s 2 (Natter et al, 1998). We used an
oligonucleotide speci®c for the 3¢ end of the a-NAC cDNA to
screen a cDNA library prepared from the human epithelial cell line,
A431 for a-NAC/Hom s 2 isoforms.
The possibility that several a-NAC isogenes may exist in humans
was analyzed by southern blot hybridization experiments. A
complete a-NAC/Hom s 2 cDNA as well as the C-terminal
portion of a-NAC/Hom s 2 were expressed in Escherichia coli to
demonstrate the IgE binding capacity of the recombinant IgE
autoantigen and to determine its IgE-reactive domains. Structural
fold of recombinant Hom (rHom) s 2 was analyzed by circular
dichroism spectroscopy. Furthermore, we investigated whether
rHom s 2 can induce speci®c lymphoproliferative responses in a
sensitized AD patient.
MATERIALS AND METHODS
Phage libraries, E. coli strains, and plasmids A cDNA library
constructed from the human epithelial cell line A431 in phage lgt11was
purchased from Clontech (Palo Alto, CA). E. coli strains Y1090 [hsd
(rk
±mk
+) lac U169, ProA+, Ion±, araD 139, StrA, Sup
FtrpC22:Tn10(pmC9)] and Y1089 [hsd (rk
±mk
+) lac U169, Pro A+, Ion_,
araD 139, StrA, h¯A 150 chr:Tn10(pMC9)] were obtained from
Amersham (Amersham, Buckinghamshire, U.K.). E. coli strain XL-1
Blue: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F¢proAB
lacIqZDEM15 Tn10(Tetr)]c, was from Stratagene (La Jolla, CA) and E.
coli strain BL21(DE3): F±,ompT rB
±mB
±(DE3) was from Novagen
(Cambridge, U.K.). Plasmid pUC19 used for subcloning was from
Boehringer (Mannheim, Germany) and plasmid pET-17b used for
overexpression in E. coli was from Novagen.
Sera, cell lines, and tissue specimens Sera were obtained from AD
patients diagnosed according to Hani®n and Rajka (1980), from patients
with allergic rhinoconjunctivitis and from nonatopic individuals by
venipuncture. The diagnosis of type I allergy was based on case history,
demonstration of speci®c IgE against environmental allergen sources by
RAST measurements and positive skin prick reactivity as described
(Niederberger et al, 1998). All sera were stored at ±20°C until use. A
human epithelial cell line (A431) derived from an epidermoid mamma
carcinoma was obtained from American Type Culture Collection
(Rockville, MD) and grown as described (Valenta et al, 1996). Human
tissue specimens containing natural Hom s 2 were obtained from biopsies
taken either ex vivo (colon) or immediately post mortem (brain-medulla)
for routine histology.
IgE immunoblotting Protein extracts were prepared by
homogenizing tissues in sodium dodecyl sulfate (SDS) sample buffer
(Laemmli, 1970), and boiling of the extracts for 5 min. Insoluble material
was removed by centrifugation in a bench fuge (12,000 r.p.m., 5 min,
room temperature). Protein extracts were separated by 12.5% SDS±
polyacrylamide gel electrophoresis (SDS±PAGE) (Fling and Gregerson,
1986) and stained with Coomassie blue (Bradford, 1976). Proteins were
transferred on to nitrocellulose membranes (Schleicher & Schuell, Dassel,
Germany) by electroblotting (Towbin et al, 1979), and membrane-bound
proteins were exposed to serum IgE as described (Valenta et al, 1996).
Bound IgE antibodies were detected with 125I-labeled anti-human IgE
antibodies (RAST, Pharmacia & Upjohn, Uppsala, Sweden) and
visualized by autoradiography. A monoclonal anti-Histag antibody was
obtained from Novagen.
Oligonucleotide screening of the A431 cDNA library In order to
obtain a complete Hom s 2 cDNA clone, we designed an
oligonucleotide probe according to the incomplete Hom s 2.02 cDNA
isolated by IgE immunoscreening (Natter et al, 1998). The
oligonucleotide 5¢-GAC TCT AGT AAC TCC TGT AAC CTG CCG
AAG ACC C-3¢ was 32P-labeled using 32P g-adenosine triphosphate and
polynucleotide kinase (Boehringer). Approximately 250,000 pfu (plaque-
forming units) of the A431 cDNA library were used to infect E. coli
Y1090 and plated at a density of 20,000 phage per plate (140 mm
diameter) and nitrocellulose ®lter replicas (Schleicher & Schuell) were
hybridized with the 32P-labeled Hom s 2.02-speci®c oligonucleotide.
Isolation and molecular characterization of a Hom s 2.01-encoding
cDNA clone Two positive clones were obtained after the ®rst round
of screening and recloned to homogeneity by three further rounds of
oligonucleotide screening. Phage DNA was isolated from the positive
clones and the cDNA inserts were excised with EcoRI, gel puri®ed, and
ligated into the EcoRI site of plasmid pUC 19 (Boehringer). Plasmids
were transformed into E. coli XL1-Blue and plasmid DNA was isolated
using Qiagen tips (Qiagen, Hilden, Germany). Both cDNA strands were
sequenced using forward and reversed primers (Boehringer), internal
primers designed according to the Hom s 2 cDNA sequence (MWG-
Biotech, Ebersberg, Germany), 35S-deoxycytidine triphosphate (NEN,
Stevenage, U.K.) and a T7 sequencing kit (Pharmacia, Uppsala, Sweden)
(Sanger et al, 1977). All molecular biologic manipulations were
performed as described in (Sambrook et al, 1989).
The McVector program (Kodak Rochester, NY) was used to establish
the amino acid sequence of the Hom s 2.01 open reading frame, to
calculate pI, molecular weight, amino acid composition, secondary
structure of Hom s 2, and to search for sequence motifs. The cDNA and
deduced amino acid sequence of Hom s 2.01 were compared with the
sequences deposited in GenBank using the BLAST program.
Southern blot experiments A431 genomic DNA was isolated by
cesium chloride density centrifugation (Sambrook et al, 1989). Five
microgram aliquots of genomic DNA were digested with either HindIII,
BamHI, KpnI, PstI, or EcoRI, separated by 1% agarose gel
electrophoresis, blotted on to nitrocellulose, and hybridized with the
complete 32P-deoxycytidine triphosphate-labeled Hom s 2.01 cDNA
(Feinberg and Vogelstein, 1983). Five micrograms of PstI-digested l
phage DNA was run on the same gel as a molecular weight standard.
The southern blot was washed up to a ®nal stringency of 0.75 3 sodium
citrate/chloride buffer, 0.1% SDS, 65°C, and was exposed to KODAK
X-OMAT ®lms using intensifying screens at ±70°C.
Expression of complete rHom s 2.01 in E. coli The coding region of
the Hom s 2.01 cDNA was polymerase chain reaction ampli®ed using
the following primer pair: Hom s 2.01 forward: 5¢-GGG ATT CCA
TAT GCC GGG CGA AGC CAC AGA AAC C-3¢; Hom s 2.01
reversed: 5¢-GGG ATT CCA TAT GTT AGT GGT GGT GGT GGT
GGT GCA CTG MA ATT OCA TAA TCG CAT-3¢. The forward
and reversed primer contained NdeI (underlined) sites to allow subcloning
into the NdeI site of plasmid pET-17b (Novagen). The thus inserted Hom
s 2.01 cDNA should allow the production of authentic rHom s 2.01
containing a C-terminal hexahistidine tag. E. coli BL21(DE3) (Novagen)
were transformed with plasmid pET-17b containing the Hom s 2.01
cDNA and positive clones were isolated by colony screening using serum
from an AD patient containing Hom s 2-speci®c IgE antibodies and an
anti-histag antibody (Novagen). For the expression in liquid culture, E.
coli BL21 (DE3) were transformed with plasmid pET 17b-Hom s 2.01 or,
for control purposes, with plasmid pET-17b alone. Fifty milliliter aliquots
of Luria Broth containing 100 mg per ml ampicillin were inoculated with
one colony obtained after transformation, grown to an OD600 of 0.3 and
induced by addition of IPTG (isopropyl-b-D-thiohalacopsranoside) to a
®nal concentration of 1 mM for 4 h. E. coli cells were harvested by
centrifugation and equal aliquots of the harvested cells were lyzed in SDS
sample buffer and analyzed by SDS±PAGE and Coomassie blue staining to
visualize overexpression of rHom s 2.01. The rest of the cellular pellet was
stored at ± 20°C until use.
Expression of the C-terminal Hom s 2.02 fragment in E. coli An 86
amino acid C-terminal fragment of Hom s 2 (Hom 2.02: Fig 1) was
expressed as b-galactosidase (b-gal) fusion protein in E. coli Y1089. E.
coli Y1089 were infected with lgt11 phage containing the Hom 2.02
cDNA (Fig 1) or, for control purposes, with empty lgt11 phage.
Lysogenic E. coli Y1089 were grown in Luria Broth medium containing
100 mg per liter ampicillin, 0.4% w/v maltose, and 10 mM MgCl2 at
32°C until an OD600 of 0.5. The culture temperature was then rapidly
shifted to 42°C for 30 min, and expression of the b-gal-fused Hom s
2.02 fragment or b-gal alone was induced at 37°C by addition of IPTG
to a ®nal concentration of 5 mM. Bacterial cells were collected by
centrifugation and stored at ±20°C until use.
Puri®cation of His-tagged rHom s 2.01 via nickel af®nity
chromatography E. coli BL21(DE3) containing the Hom s 2-
expressing pET-17b construct were grown in Luria Broth containing
ampicillin to an OD600 of 0.3. Protein expression was induced by
addition of IPTG to a ®nal concentration of 0.5 mM and growth at
32°C. Cells were harvested by centrifugation and homogenized in
25 mM imidazole pH 8.0, 0.1% Triton, 1 mM phenylmethylsulfonyl
¯uoride using an ultraturrax (Ika, Staufen, Germany). Insoluble material
was removed by centrifugation at 30,000 3 g at 4°C and the supernatant
was dialyzed against 50 mM NaH2PO4, pH 8.0, 300 mM NaCl, and
10 mM imidazole. The dialysate was applied to Ni-NTA sepharose
(Qiagen). The Ni-NTA sepharose column was then washed with two
volumes of 50 mM NaH2PO4, pH 8.0, 300 mM NaCl, 20 mM
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imidazole, and rHom s 2 was eluted with 50 mM NaH2PO4 pH 8.0,
300 mM NaCl, 250 mM imidazole. Fractions containing the puri®ed
recombinant protein were dialyzed against H2Odd. The protein
concentration was determined by BCA assay (Pierce, Rockford, IL).
IgE reactivity of rHom s 2.01 and the rHom s 2.02
fragment Comparable amounts of E. coli Y1089 expressing b-gal fused
Hom s 2.02 or b-gal alone were extracted in SDS sample buffer,
separated by SDS±PAGE (12.5% SDS±PAGE: rHom s 2.01; 8% SDS±
PAGE: b-gal fused Hom s 2.02), and blotted on to nitrocellulose.
Nitrocelluloses were incubated with serum from an AD patient with and
without Hom s 2-speci®c IgE but containing comparable levels of total
serum IgE (2000 KUIL per liter), with sera from ®ve allergic individuals
without Hom s 2-speci®c IgE antibodies and with sera from two
nonatopic individuals as described (Natter et al, 1998). Bound IgE
antibodies were detected with 125I-labeled anti-human IgE antibodies
(RAST, Pharmacia) and visualized by autoradiography.
IgE reactivity to puri®ed rHom s 2 was studied by Western blot and
enzyme-linked immunosorbent assay. Nitrocellulose membranes contain-
ing puri®ed Hom s 2 (5 mg per cm preparative gel) were incubated with
sera from atopic patients with or without Hom s 2-speci®c IgE and with
serum from a nonatopic individual as described (Natter et al, 1998).
Bound IgE antibodies were detected with 125I-labeled anti-human IgE
antibodies (Pharmacia) and visualized by autoradiography. For enzyme-
Figure 2. Alignment of the deduced amino acid sequence of Hom s 2.01 with homologous proteins. Identical amino acids are indicated by
dashes. Gaps are indicated by points. Asterisks indicate regions where amino acids were removed to allow optimal alignment (Arabidopsis: 143±144, SM;
Drosophila: 3±5, ELT; 20, K; 162, A; S. pombe. 17±23, GSTTVVH; 87±93, AFNESQK; S. cerevisiae 91±107, EDVATKSPEDIQADMQA). Two N-
linked glycosylation sites are bold, the protein kinase C site is underlined and the protein kinase C phosphorylation sites are indicated in italics.
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linked immunosorbent assay detection of Hom s 2-speci®c IgE and IgG
subclass responses, enzyme-linked immunosorbent assay plates (Nunc
Maxisorb, Roskilde, Denmark) were coated with 5 mg per ml of puri®ed
rHom s 2 and for control purposes, with the puri®ed dog allergen, Can f
3 (Spitzauer et al, 1995). Speci®c IgE and IgG1±4 subclass responses were
detected as described (Vrtala et al, 1996). Results are displayed as mean
values with an experimental error of < 5%.
IgE inhibition experiments Cross-reactivity of rHom s 2 with its
human colon-derived natural counterpart was investigated by IgE
immunoblot inhibition experiments. Bacterial extracts containing rHom s
2.01 or without rHom s 2.02 were obtained by homogenization of E.
coli BL21 (DE3) in phosphate-buffered saline with an ultraturrax. Sera
from a Hom s 2 reactive and another AD patient without Hom s 2-
speci®c IgE or serum dilution buffer (buffer A: 50 mM Na phosphate
pH 7.5, 0.5% w/v bovine serum albumin, 0.5% v/v Tween 20, 0.05%
w/v NaN3) were preadsorbed with equal amounts of bacterial protein
extracts (1 ml of a 1 : 10 diluted serum was preadsorbed with 100 ml
containing approximately 100 mg bacterial protein extract) overnight at
4°C. Nitrocellulose strips containing blotted human tissue extracts were
blocked in buffer A and incubated with the pretreated sera or buffer
overnight at 4°C. Bound IgE antibodies were detected with 125I-labeled
anti-human IgE antibodies (RAST, Pharmacia) as described (Natter et al,
1998).
Circular dichroism analysis Circular dichroism measurements were
performed in MilliQ water pH 7.3 with a protein concentration of
1.12 3 10±5 M as determined by BCA assay (BCA Protein assay
Reagent, Pierce). The investigations were carried out on a Jasco J-715
spectropolarimeter using a 0.1 cm pathlength cell with cooling jacket
connected to a water thermostating device. The sample was heated to
95°C with a heat rate of 1°C per min and cooled down using the same
parameters. A continuous temperature scan was performed at 222 nm
with a step resolution of 0.5°C and a wait time of 1 min. Spectra were
recorded at 20, 40, 60, 80, and 95°C with 0.2 nm resolution at a scan
speed of 50 nm per min and resulted from averaging ®ve scans. The ®nal
spectra were baseline corrected by subtracting the corresponding MilliQ
spectra obtained under identical conditions. Results were expressed as
the mean residue ellipticity [Q] at a given wavelength. The data were
®tted with the secondary structure estimation program J-700 (J-700 for
Windows Secondary Structure Estimation, version 1.10.00, copyright
1993±94 JASCO Corp., Tokyo, Japan) according to (Yang et al, 1986)
using the ®nite-mode ®tting procedure.
Lymphoproliferation assays Peripheral blood mononuclear cells
(PBMC) were isolated from AD patients by Ficoll (Amersham Pharmacia
Biotech, Little Chalfont, U.K.) density gradient centrifugation. AD
patients containing comparable levels of total IgE with and, for control
purposes, without Hom s 2-speci®c IgE antibodies were investigated.
PBMC (2 3 105) were cultured in triplicates in 96-well plates
(Nunclone, Nalgen Nunc International, Roskilde, Denmark) in 200 ml
serum-free Ultra Culture medium (BioWhittaker, Rockland, ME)
supplemented with 2 mM L-glutamine (Sigma, St Louis, MO), 50 mM b-
mercaptoethanol (Sigma) and 0.1 mg gentamicin per ml (Sigma) at 37°C
using 5% CO2 in a humidi®ed atmosphere. Cells were stimulated with
different concentrations (0.6±5 mg per well) of Hom s 2 and, for control
purposes, with an environmental allergen, the dog allergen Can f 3 (dog
albumin), 4 U interleukin-2 per well (Boehringer) or medium alone.
After 6 d culture, 0.5 mCi per well 3H-thymidine (Amersham Pharmacia
Biotech) was added and 16 h thereafter incorporated radioactivity was
measured by liquid scintillation counting using a microbeta scintillation
counter (Wallac ADL, Freiburg, Germany) and mean cpm were
calculated from the triplicates. The stimulation index (SI) was calculated
as the quotient of the cpm obtained by antigen or interleukin-2
stimulation and the unstimulated medium control. All proliferation
experiments were repeated at least once.
RESULTS
Isolation and characterization of a cDNA coding for a
complete a-NAC/Hom s 2.01 isoform The cDNA isolated
by screening with an oligonucleotide speci®c for the partial Hom s
2 cDNA, represented an isoform with nucleotide exchanges in 31
triplets compared with the a-NAC cDNA sequence (Fig 1). An
open reading frame of 645 base pairs, including the methionine-
encoding start codon (ATG) coded for a Hom s 2.01 polypeptide of
215 amino acids. The partial cDNA clone isolated by IgE
immunoscreening out of the same cDNA library coded for a 86
amino acid long fragment.
C-terminal Hom s 2 portion (Natter et al, 1998), which was
identical to the previously published a-NAC sequence, however,
was different from the Hom s 2.01 sequence and therefore was
designated according to the Allergen nomenclature Hom s 2.02.
The Hom s 2.01 protein deduced from the cDNA sequence
represents an acidic polypeptide (calculated pI: 4.48) with a
calculated molecular mass of 23.2 kDa. It is rich in alanine
(11.16%), valine (10.23%), and glutamic acid (11.63%) residues and
lacks cysteines and histidines. Amino acid residues with high surface
probability, ¯exibility, and high antigenic index were predicted to
be scattered throughout the protein. The secondary structure
prediction according to Chou and Fasman (1974) and Garnier et al
(1978) indicated that the protein consists mostly of a-helical
secondary structure with only one area assuming predicted b-sheet
conformation (amino acids 80±120). A search for protein motifs
revealed the presence of two N-linked glycosylation sites (Fig 2:
bold), one protein kinase C site (Fig 2: underlined), and two
protein kinase C phosphorylation sites (Fig 2: italics).
Hom s 2 is homologous to a-NAC-related proteins from
various species When the databases for proteins with signi®cant
sequence homology to Hom s 2.01 were searched, several highly
homologous proteins were found in mouse, fruit ¯y, plants
(Arabidopsis thaliana), yeast, and protozoa (Fig 2). Hom s 2.01
can be considered a true isoform of human a-NAC because it
contained 21 amino acid exchanges compared with human a-
NAC.
The deduced amino acid sequence of Hom s 2.01 shared the
highest degree of end to end sequence identity with the a-NAC
protein from mouse (90.23%). Signi®cant homologies were found
with putative a-NAC sequences found in Arabidopsis (45.12%) and
fruit ¯y (Drosophila melanogaster) (52.55%). The Hom s 2.02
homologs from Schizosaccharomyces pombe and S. cerevisiae were
shorter than the other a-NAC proteins and several amino acids had
to be removed to allow optimal sequence alignment. The sequence
identity between Hom s 2.01 and homologs from S. pombe and S.
cerevisiae were 42.77% and 36.13%, respectively. Hom s 2.01
homologous sequences were found also in protozoa (Leishmania
donovani), which exhibited a 39.55% sequence identity with Hom s
2.01. The N-linked glycosylation sites, phosphorylation sites and
protein kinase C sites predicted for Hom s 2.01 were conserved in
a-NAC proteins of mammalian origin. Overall, we noticed that
the C-terminal portions of the Hom s 2.01-related proteins that
contained a major IgE-reactive domain represented the most
conserved protein domains among the a-NAC homologous
proteins.
The Hom s 2.01 cDNA hybridizes with several restriction
fragments in human genomic DNA: evidence for a Hom s 2
gene family Our ®nding that the Hom s 2.01 cDNA differed
from the a-NAC cDNA sequence indicated the occurrence of
several a-NAC isogenes (Figs 1 and 2). Hybridization of human
genomic DNA digested with enzymes that do not cut in the Hom s
2.01 cDNA (Fig 3: HindIII, BamHI, KpnI, PstI, EcoRI) showed
that several restriction fragments hybridized with the Hom s 2.01
cDNA: At least four hybridizing fragments were detected in PstI-
and EcoRI-digested DNA, three fragments in HindIII-digested
DNA bound to the probe and two fragments in BamHI- and KpnI-
digested DNA were detected by the Hom s 2.01 cDNA. All but
one restriction fragment (a 600 base pair fragment in PstI-digested
DNA) were larger than the Hom s 2.02 cDNA. Although we have
at present no information regarding the occurrence of introns in the
Hom s 2/a-NAC gene, the hybridization data together with the
Hom s 2.01 sequence strongly indicate that human a-NAC is
encoded by a gene family.
Identi®cation of the C-terminal portion of Hom s 2 as an
IgE-reactive fragment In order to determine whether the C-
terminal portion of Hom s 2 contains IgE epitopes, we tested the
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recombinant C-terminal b-gal-fused Hom s 2 (Hom s 2.02)
fragment and, for control purposes, b-gal alone with serum IgE
from a Hom s 2-reactive AD patient. Serum IgE of the Hom s 2-
reactive patient (Fig 4: lane 1) but not from an AD patient
containing comparable levels of total IgE (Fig 4: lane 2) reacted
with the b-gal-fused C-terminal portion of Hom s 2 at
approximately 120 kDa. The molecular weight of the IgE-
reactive band is due to the fusion of the C-terminal Hom s 2
fragment with the 110 kDa b-gal. When extracts were incubated
with buffer but without addition of serum (Fig 4: lane b) no
reactivity was observed.
Puri®cation of complete rHom s 2.01 via nickel af®nity
chromatography The SDS±PAGE analysis of extracts from
induced E. coli BL21 (DE3) containing the Hom s 2.01-expressing
plasmid revealed overexpression of rHom s 2.01 at approximately
33 kDa and of a protein band of > 200 kDa (Fig 5: ExtractÐ
Coomassie, lane +). Using nickel af®nity chromatography, a rHom
s 2.01 could be puri®ed as a major component of 33 kDa (Fig 5:
Coomassie, puri®ed). Typical expression yields were in the range of
3±5 mg protein per liter culture. In addition to the 33 kDa
component a moiety of > 200 kDa and a few weak bands of
< 33 kDa were copuri®ed by nickel af®nity chromatography,
which reacted with the monoclonal anti-Histag antibody and with
serum IgE from a Hom s 2-reactive AD patient (Fig 5: IgE, lane 4).
AD patients containing comparable levels of total serum IgE as the
Hom s 2-reactive patient did not show IgE reactivity with puri®ed
rHom s 2.01 (Fig 5: lanes 1±3). Sera from a rhinoconjunctivitis
patient and a nonatopic individual without Hom s 2-speci®c IgE
did not exhibit IgE reactivity with the af®nity puri®ed rHom s 2.01
(Fig 5: lanes 5 and 6).
Recombinant E. coli-expressed Hom s 2.01 inhibits IgE
binding to its natural counterpart Next we were interested
to study whether E. coli-expressed Hom s 2.01 shares IgE epitopes
with its natural counterpart. As tissues of the gastrointestinal tract
are rich in a-NAC (Wiedmann et al, 1994) we prepared extracts
from human colon tissue specimens. Preincubation of serum from a
Hom s 2-reactive AD patient with rHom s 2.01 (Fig 6: lane 1a) but
not with bacterial extract alone (Fig 6: lane 1) lead to a reduction
of IgE reactivity to 30 kDa, 14 kDa, and 8 kDa components in
Figure 3. Hybridization of the Hom s 2.01 cDNA with
nitrocellulose blotted human genomic DNA prepared from A431
cells. Five microgram aliquots of genomic DNA were digested with
HindIII (lane 1), BamHI (lane 2), KpnI (lane 3), PstI (lane 4), and EcoRI
(lane 5), separated by 1% agarose gel electrophoresis and blotted on to
nitrocellulose. The membrane was hybridized with the complete Hom s
2.01 cDNA (Fig 1). Molecular weights (PstI digested l DNA) are
displayed on the left margin in base pairs (bp).
Figure 4. IgE binding capacity of a recombinant C-terminal
Hom s 2.02 fragment. The C-terminal Hom s 2.02 fragment was
expressed as a b-gal fusion protein. Nitrocellulose-blotted bacterial
extracts containing the b-gal-fused C-terminal Hom s 2.02 fragment
(block: Hom s 2.02) or b-gal alone (block: b-gal) were exposed to
serum IgE from an AD patient with (lane 1) and without (lane 2) Hom s
2-speci®c IgE. Both sera contained comparable levels of total serum IgE.
Lane b represents the buffer controls. Bound IgE antibodies were
detected with 125I-labeled anti-human IgE antibodies and visualized by
autoradiography. Molecular weights (kDa) are indicated on the left
margin.
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blotted colon extracts. Serum from an AD patient without Hom s
2-speci®c IgE did not exhibit IgE reactivity to nitrocellulose-
blotted human colon extract (Fig 6: lanes 2 and 2a). When blots
were incubated with buffer without addition of serum no reactivity
was observed (Fig 6: lanes 3 and 3a). Similar results were obtained
when IgE inhibition studies were performed with nitrocellulose-
blotted extracts from human stomach and brain: rHom s 2 inhibited
IgE binding of the Hom s 2-reactive serum to components of
approximately 30 kDa and lower molecular weights (data not
shown).
rHom s 2 is a thermostable protein of mixed a-helical and b-
sheet conformation with high refolding capacity The far
ultraviolet spectra indicate that the protein contains a considerable
amount of secondary structure. The spectra are dominated by an a-
helical minimum at 208 nm, a characteristic rise towards a
maximum below 195 nm and a shoulder between 215 and
220 nm (Fig 7). Fitting the secondary structure yields a mixed
a/b-fold with 18.5% a-helix content (data not shown). This
corresponds with the results derived from secondary structure
prediction based on the amino acid sequence (PHD program: Rost
and Sander, 1993; Rost, 1996) (data not shown). The rHom s 2.01
protein turns out to be remarkably stable in heat denaturation
experiments. In a temperature scan a reversible folding transition is
observed at 55 6 3°C (data not shown). Even at a temperature of
95°C a considerable amount of secondary structure still exists
(Fig 7). Upon annealing to 20°C rHom s 2.01 essentially regains its
initial secondary structure.
rHom s 2 induces speci®c lymphoproliferation Two AD
patients containing comparable total serum IgE levels, one with
(Table I, Fig 8: patient 1) and one without Hom s 2-speci®c IgE
(Table I, Fig 8: patient 2) were studied by lymphoproliferation
assays. In two independently performed experiments similar results
were obtained: different concentrations of rHom s 2 (0.6 mg per
well, 2.5 mg per well) induced speci®c lymphoproliferative
responses (stimulation indices > 2.5) in PBMC of the rHom s 2-
reactive (patient 1) but not in the other AD patient (patient 2)
without Hom s 2-speci®c IgE (Fig 8). Only the AD patient 2 with
IgE antibodies against the dog allergen, Can f 3, but not AD patient
1 without Can f 3-speci®c IgE showed proliferative responses
(stimulation indices > 2.5) to Can f 3 (Fig 8). PBMC of both AD
patients showed proliferation (SI between 5 and 7) after addition of
interleukin-2. Table I displays the IgE and IgG subclass reactivity
of the two AD patients to rHom s 2 and Can f 3 as determined by
enzyme-linked immunosorbent assay (Vrtala et al, 1996). As
observed previously for environmental allergens, IgE reactivity to
Hom s 2 was not strictly associated with IgG subclass reactivity
(Valenta and Ball, 1997).
DISCUSSION
Using serum IgE from an AD patient we have previously isolated a
partial cDNA clone coding for the 86 C-terminal amino acids of
human a-NAC, a component of a heterodimeric protein complex,
NAC, which is required for signal-sequence-speci®c sorting and
translocation of nascent polypeptides emerging from the ribosomes
Figure 5. Expression of rHom s 2.01 in E. coli. Total protein extracts from E. coli BL21 (DE3) obtained before (±) and after induction (+) of
protein expression with IPTG and puri®ed rHom s 2.01 were separated by SDS±PAGE and stained with Coomassie blue. Nitrocellulose-blotted
puri®ed rHom s 2.01 was exposed to an alkaline phosphatase conjugated anti-Histag antibody (aHistag), to serum IgE from four patients with AD
(lanes 1±4), a patient with allergic rhinoconjunctivitis (lane 5) and a nonatopic individual (lane 6). Molecular weights are displayed in kDa on the right
margins.
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in human and other mammalian cells (Wiedmann et al, 1994;
Natter et al, 1998). In addition murine a-NAC has been also
identi®ed as a transcriptional coactivator (Yotov and St Arnaud,
1996).
In this study we isolated by oligonucleotide screening of a
human epithelial cDNA library a cDNA coding for a complete
human a-NAC isoform, which differs in 21 of 215 amino acids
from the previously described human a-NAC form. Further
support for our assumption that several a-NAC isoforms exist in
humans was obtained by Southern blot experiments where we
demonstrated that digestion of human genomic DNA with
enzymes that do not cut in the a-NAC-encoding cDNA yielded
several bands capable of hybridizing with the a-NAC cDNA
probe.
Although a-NAC represents a phylogenetically conserved
protein with important biologic functions, there is to date no
report regarding the molecular characterization of a folded
recombinant a-NAC protein. In order to obtain a folded
recombinant a-NAC protein as a paradigmatic tool for immuno-
logic experiments we used the cDNA coding for the human a-
NAC isoform isolated in our study to express recombinant human
a-NAC as His-tagged protein in E. coli. Using nickel af®nity
chromatography we were able to purify milligram amounts of
soluble recombinant human a-NAC. Circular dichroism analysis
demonstrated that recombinant a-NAC represented a folded
protein consisting of mixed a-helical and b-sheet conformation
and exhibited a remarkable thermal stability and refolding capacity.
This feature has been reported for chaperone-like proteins and
seems to be common to many important environmental allergens
(Laffer et al, 1996; Hayek et al, 1998; Mittermann et al, 1998;
DeMarino et al, 1999; Niederberger et al, 1999; Vrtala et al, 1999;
Bugajska-Schretter et al, 2000).
Using recombinant a-NAC we were able to document its
immunologic equivalence with natural a-NAC by IgE inhibition
experiments and demonstrate the speci®c reactivity of recombinant
a-NAC with IgE autoantibodies. The recombinant a-NAC
isoform described in our study was therefore designated Hom s
2.01 according to the Allergen Nomenclature System. It may be
used to identify atopic patients containing IgE autoantibodies
against a-NAC. The latter assumption is supported by our ®nding
that rHom s 2.01 such as environmental allergens, can be used in
enzyme-linked immunosorbent assay assays to identify atopic
Figure 6. rHom s 2.01 inhibits IgE binding to its natural
counterpart. Nitrocellulose-blotted human colon extract was incubated
with serum from an AD patient with (lane 1) and without (lane 2) rHom s
2.01-reactive IgE as well as with buffer alone (lane 3). In the ®rst lane, sera
were preadsorbed with E. coli extract containing rHom s 2.01 and in lane a
with E. coli extract alone. Bound IgE antibodies were detected with 125I-
labeled anti-human IgE antibodies and visualized by autoradiography.
Molecular weights (kDa) are indicated on the right margin.
Figure 7. Circular dichroism analysis of puri®ed rHom s 2.01 at
various temperatures. The plot of the mean residue molar ellipticity
shows a mixed a/b-fold at 20°C (full dots). A slight unfolding can be
observed at 95°C (crosses), but after re-annealing to 20°C (open
triangles) the initial secondary structure is mostly regained.
Table I. IgE and IgG subclass reactivity to rHom s 2.01.
Optical density values corresponding to the levels of IgE and
IgG1±4 antibodies speci®c for rHom s 2 and the dog allergen Can
f 3 are displayed for sera from the two AD patients (1, 2) which
were analyzed for Hom s 2-speci®c lymphoproliferative responses
in Fig 8
rHom s 2 Can d 3
No. 1 IgE 0.228 0
IgG1 0.041 0
IgG2 0 0
IgG3 0 0
IgG4 0.066 0
No. 2 IgE 0 0.961
IgG1 0.015 0.198
IgG2 0.054 0.031
IgG3 0 0
IgG4 0.024 0.510
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patients containing speci®c IgE autoantibodies. In this context it
was of note that the C-terminus of Hom s 2, which represented the
most conserved portion of a-NAC-homologous proteins from
animals, insects, yeast, plants, and protozoa, contained binding sites
for IgE autoantibodies. At present, however, we do not have a
de®nitive answer to the question whether a-NAC-reactive patients
were originally sensitized against an a-NAC-homologous protein
from plants, yeast, or insects and then started to exhibit IgE cross-
reactivity to endogenous a-NAC or whether they were primarily
sensitized against endogenous a-NAC.
AD represents a chronic skin manifestation of atopy and it is well
established that T cell reactivity to exogenous allergens represents a
prominent feature of AD (Rawle et al, 1984). These T cells can be
found in the circulation of AD patients but also home to the skin
where they can give rise to positive atopy patch test reactions (Van
Reijsen et al, 1992; Santamaria-Babi et al, 1995; Wistokat-Wul®ng
et al, 1999). Using rHom s 2 we show that AD patients containing
IgE autoantibodies can also exhibit speci®c lymphoproliferative
responses to IgE-de®ned autoantigens. It is thus possible that T cell
reactivity to autoantigens, such as T cell reactivity to exogenous
allergens, may represent a pathomechanism in AD. Although only
very few patients (approximately 1% of AD patients) contained a-
NAC-speci®c IgE autoantibodies, we think that recombinant a-
NAC may serve also as a paradigmatic tool to study further
mechanisms of IgE autosensitization, e.g., by establishing experi-
mental animal models for IgE autoreactivity (Herz et al, 1997;
Neuhaus-Steinmetz et al, 2000).
This study was supported by grants F0506 and F01804 of the Austrian Science
Fund.
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